Credit Inflation and IDR Exchange Rate Effects on Equity Mutual Fund NAV: The Mediating Role of IDX Composite
Financial Analytics and Economic Innovation Journal · 2026
DOI: 10.52909/faeij.v1i1.268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Financial Analytics and Economic Innovation Journal, 2026. Verfasst von Luqman Hakim und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
This study examines the effects of inflation and the IDR/USD exchange rate on the Net Asset Value (NAV) of Indonesian equity mutual funds (2015–2019), with the IDX Composite as a mediating variable, providing insights for investors, policymakers, and fund managers. Methodology: A quantitative associative design using panel data from 61 equity mutual funds registered with OJK was employed. Data were sourced from OJK, Bank Indonesia, and IDX. Partial Least Squares Structural Equation Modeling (PLS-SEM) with SmartPLS tested direct effects (inflation and exchange rate on IDX Composite and NAV) and indirect effects (IDX Composite as mediator), with bootstrapping applied for path significance.
Results
Inflation negatively affects IDX Composite (β = −0.786, p = 0.010) and NAV (β=−0.672, p=0.032), while the IDR exchange rate positively affects IDX Composite (β=0.498, p
Zitieren
APA
Hakim, L., Ikra, M., & Nuraeni, N. (2026). Credit Inflation and IDR Exchange Rate Effects on Equity Mutual Fund NAV: The Mediating Role of IDX Composite. Financial Analytics and Economic Innovation Journal. https://doi.org/10.52909/faeij.v1i1.268
Vancouver
Hakim L, Ikra M, Nuraeni N. Credit Inflation and IDR Exchange Rate Effects on Equity Mutual Fund NAV: The Mediating Role of IDX Composite. Financial Analytics and Economic Innovation Journal. 2026. doi:10.52909/faeij.v1i1.268
BibTeX
@article{Hakim2026,
author = {Hakim, Luqman and Ikra, Muhammad and Nuraeni, Nuraeni},
title = {Credit Inflation and IDR Exchange Rate Effects on Equity Mutual Fund NAV: The Mediating Role of IDX Composite},
journal = {Financial Analytics and Economic Innovation Journal},
year = {2026},
doi = {10.52909/faeij.v1i1.268}
}
EUVIMED